News
 
Bookmark and Share
A A A
Feed icon

News

chromosome 22q deletion

Parkinson's chromosome deletion linked to other genetic disorders

Researchers, led by BRC-supported Professor Nicholas Wood, UCL Institute of Neurology, have made a breakthrough in their understanding of Parkinson’s disease after they discovered a chromosome deletion linked to Parkinson’s disease and other genetic disorders. More...

Prof John Hardy

Prof John Hardy is the first UK winner of $3m Breakthrough Prize in Life Sciences

Professor John Hardy (UCL Institute of Neurology) has been awarded the $3 million Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease. More...

John Hardy, PhD, right, accepted the 2015 Robert A. Pritzker Prize from MJFF VP Brian Fiske, PhD, and Michael J. Fox on April 15.

John Hardy awarded 2015 Robert A. Pritzker Prize for Leadership in Parkinson's Research

One of the UK Parkinson's Disease Consortium Principal Investigators, Prof John Hardy, has been awarded the 2015 Robert A. Pritzker Prize for his leadership in Parkinson's genetics research. The award was presented by Michael J. Fox at a ceremony in New York on April 15. From the Michael J. Fox Foundation website: More...

Webcast - Prof Nicholas Wood - Advances in Genetic Understanding of Parkinson's Disease.

Video: Advances in Genetic Understanding of Parkinson's Disease

Webcast of the presentation entitled ‘Advances in Genetic Understanding of Parkinson's Disease’ given by Nicholas Wood (University College London, United Kingdom) presented at the Biochemical Society Hot Topic event, PINK1-Parkin Signalling in Parkinson’s Disease and Beyond, held in December 2014. More...

Pedigrees and I-FP-CIT SPECT scan images of the four families with GCH1 mutations involved in this study.

GCH1 gene and Parkinson's risk

A study published in Brain, led by researchers at UCL Institute of Neurology, has shown that genetic mutations which cause a decrease in dopamine production in the brain and lead to a form of childhood-onset Dystonia, also play a role in the development of Parkinson’s disease.
More...

Prof John Hardy is the first UK winner of $3m Breakthrough Prize in Life Sciences

9 November 2015

Professor John Hardy (UCL Institute of Neurology) has been awarded the $3 million Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease.

Prof John Hardy

The Breakthrough Prize in Life Sciences honours ‘transformative advances toward understanding living systems and extending human life’. This is the first time that the prize has been awarded to a UK researcher, reflecting UCL’s world-leading position in dementia research.

Professor John Hardy said: “It is a great honour to be awarded the prize for our work dissecting the causes of Alzheimer and Parkinson's diseases. It is, of course, our hope and aim that this understanding leads to effective treatments. At UCL with the Alzheimer's Research UK Drug Discovery Institute, the Leonard Wolfson Experimental Neurology Centre and the fantastic clinical team we have at the Institute of Neurology, I feel we can beat these diseases.”

Professor Hardy has generously agreed to give £50,000 from the prize money to match donations towards the construction of the new Dementia Research Institute at UCL. The Institute will bring together researchers from across UCL and UCLH to lead national and international efforts to find effective treatments and improve the lives of those with dementia.

UCL President & Provost, Professor Michael Arthur, said: “John Hardy is a humble and hard-working scientist, so I am delighted that his pioneering work into the genetics of Alzheimer’s has been recognised by the award of the Breakthrough Prize in Life Sciences. I would like to thank John for his commitment to contribute generously towards the new Dementia Research Institute at UCL, which aims to find effective treatments and improve the lives of those with dementia. This exemplifies the tireless dedication that John has always shown to his work at the UCL Institute of Neurology and I am extremely proud of what he has achieved and continues to achieve.”

Using innovative genetic analysis methods, Professor Hardy has made major contributions to the study of almost all major neurodegenerative diseases. He has published over 850 scientific papers, many of which are focused on neurological disorders and more specifically the genetics of Alzheimer’s disease. His research has underpinned nearly all basic science and treatment research into Alzheimer’s disease over the last 20 years.

Professor Alan Thompson, Dean of the UCL Faculty of Brain Sciences, says: “This exciting and extremely prestigious prize recognises Professor John Hardy’s pivotal role in advancing our understanding in a number of major, disabling neurodegenerative diseases, in particular Alzheimer’s disease and Parkinson’s disease. The discoveries made by John and his team laid the foundations for much of the broad base of dementia research that takes place at UCL today. It is therefore fitting that his generous donation will help us to build the new Dementia Research Institute at UCL to further coordinate our efforts to tackle this dreadful condition.”

Matched donations page for the Dementia Research Institute

Media coverage

Page last modified on 09 nov 15 12:59